Dicerna Pharmaceutic (DRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2012 | 09-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||
| Net Income | -10,120 | -11,634 | -8,550 |
| Depreciation Amortization | 770 | 580 | 820 |
| Accounts payable and accrued liabilities | N/A | -668 | N/A |
| Other Working Capital | -5,030 | -493 | 610 |
| Other Operating Activity | -1,350 | 648 | -1,740 |
| Operating Cash Flow | $-15,730 | $-11,567 | $-8,860 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -120 | -120 | -500 |
| Investing Cash Flow | $-120 | $-120 | $-500 |
| Cash Flows From Financing Activities | |||
| Debt Repayment | N/A | -1,999 | N/A |
| Other Financing Activity | -2,960 | 0 | 7,250 |
| Financing Cash Flow | $-2,960 | $-1,999 | $7,250 |
| Beginning Cash Position | 22,490 | 22,490 | 24,600 |
| End Cash Position | 3,670 | 8,804 | 22,490 |
| Net Cash Flow | $-18,820 | $-13,686 | $-2,110 |
| Free Cash Flow | |||
| Operating Cash Flow | -15,730 | -11,567 | -8,860 |
| Capital Expenditure | N/A | -120 | N/A |
| Free Cash Flow | -15,730 | -11,687 | -8,860 |